Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan_老虎社区_美港股上老虎

Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan

Reuters2021-11-10

TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday. Pfizer's ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Grit100
·2021-11-10
Like n comment pls. Thx
回复
点赞
举报
Ivanhojh
·2021-11-10
Like pls
回复
点赞
举报
mei2302
·2021-11-10
Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…
回复
点赞
举报
wywy
·2021-11-10
Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
回复
4
举报
xxbbew
·2021-11-10
Like
回复
2
举报
收起
- JQing:
  👍
  2021-11-10
  回复
  举报
senglee
·2021-11-10
Okok
回复
3
举报
收起
- xxbbew:
  Ok
  2021-11-10
  回复
  举报
- senglee:
  okok
  2021-11-10
  回复
  举报
Patek1975
·2021-11-10
Buy to the moon
回复
2
举报
收起
- JCinvest:
  Yaaa
  2021-11-10
  回复
  举报
assassinyj
·2021-11-10
😄
回复
4
举报
收起
- assassinyj:
  ha ha
  2021-11-10
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2182408236?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-10 14:57","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2182408236","market":"us","top_or_hot":-1,"title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","media":"Reuters","content":"<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","article_id":"2182408236","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","pubTimestamp":1636527423,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"辉瑞申请日本5-11岁儿童新冠疫苗批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":847530670,"gmtCreate":1636533164532,"gmtModify":1636533324882,"author":{"id":"3581502897038686","authorId":"3581502897038686","name":"Grit100","avatar":"https://static.tigerbbs.com/c3c65cb20cfcce91cc07fddb27bc3ccd","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581502897038686","idStr":"3581502897038686"},"htmlText":"Like n comment pls. Thx","listText":"Like n comment pls. Thx","text":"Like n comment pls. Thx","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847530670","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847242892,"gmtCreate":1636529323359,"gmtModify":1636529416455,"author":{"id":"3575241823069388","authorId":"3575241823069388","name":"Ivanhojh","avatar":"https://static.tigerbbs.com/a41f0bf4ce9ad13477b3d5ba49c8d025","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3575241823069388","idStr":"3575241823069388"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847242892","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847246489,"gmtCreate":1636529265237,"gmtModify":1636530080566,"author":{"id":"3581653206217934","authorId":"3581653206217934","name":"mei2302","avatar":"https://static.tigerbbs.com/f8d4a2b017d4591be698aae349b7d2ce","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581653206217934","idStr":"3581653206217934"},"htmlText":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…&nbsp;","listText":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…&nbsp;","text":"Singapore will likely to be the next to approve the vaccination soon too! No wonder the stock price went up…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847246489","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847243721,"gmtCreate":1636528703632,"gmtModify":1636530086568,"author":{"id":"3566982670449095","authorId":"3566982670449095","name":"wywy","avatar":"https://static.tigerbbs.com/76ed86374fc7b16c12094c45ea30787c","vip":2,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3566982670449095","idStr":"3566982670449095"},"htmlText":"&nbsp;Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","listText":"&nbsp;Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","text":"Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847243721","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":847243143,"gmtCreate":1636528636089,"gmtModify":1636528657806,"author":{"id":"3573467106982618","authorId":"3573467106982618","name":"xxbbew","avatar":"https://static.tigerbbs.com/39068f2ebe66e4e0b64c90ad557577c0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3573467106982618","idStr":"3573467106982618"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847243143","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522950,"gmtCreate":1636528909508,"gmtModify":1636528909537,"authorId":3575867559801093,"author":{"id":3575867559801093,"idStr":"3575867559801093","authorId":3575867559801093,"name":"JQing","avatar":"https://static.tigerbbs.com/ed5b621dfa986aa908cbc70f2a608ac8","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847243143,"type":1,"supId":0,"prevId":0,"content":"👍","text":"👍","html":"👍"}],"langContent":"CN"},{"id":847240006,"gmtCreate":1636528251970,"gmtModify":1636528252211,"author":{"id":"3567638399995673","authorId":"3567638399995673","name":"senglee","avatar":"https://static.tigerbbs.com/0c8e58d61d01e30569a28e4e9c648c8f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3567638399995673","idStr":"3567638399995673"},"htmlText":"Okok","listText":"Okok","text":"Okok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/847240006","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522924,"gmtCreate":1636528640762,"gmtModify":1636528640874,"authorId":3573467106982618,"author":{"id":3573467106982618,"idStr":"3573467106982618","authorId":3573467106982618,"name":"xxbbew","avatar":"https://static.tigerbbs.com/39068f2ebe66e4e0b64c90ad557577c0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847240006,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6522875,"gmtCreate":1636528287864,"gmtModify":1636528287891,"authorId":3567638399995673,"author":{"id":3567638399995673,"idStr":"3567638399995673","authorId":3567638399995673,"name":"senglee","avatar":"https://static.tigerbbs.com/0c8e58d61d01e30569a28e4e9c648c8f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847240006,"type":1,"supId":0,"prevId":0,"content":"<u>okok</u>","text":"<u>okok</u>","html":"<u>okok</u>"}],"langContent":"CN"},{"id":847254685,"gmtCreate":1636527928621,"gmtModify":1636527928911,"author":{"id":"3566293775093626","authorId":"3566293775093626","name":"Patek1975","avatar":"https://static.tigerbbs.com/a2e5f9a5d563704aaf5f2473be16f148","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3566293775093626","idStr":"3566293775093626"},"htmlText":"Buy to the moon&nbsp;","listText":"Buy to the moon&nbsp;","text":"Buy to the moon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847254685","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522850,"gmtCreate":1636528047119,"gmtModify":1636528047228,"authorId":3585469772373012,"author":{"id":3585469772373012,"idStr":"3585469772373012","authorId":3585469772373012,"name":"JCinvest","avatar":"https://static.tigerbbs.com/b448a34b681278065a05698ba3728bbb","vip":1,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847254685,"type":1,"supId":0,"prevId":0,"content":"<u>Yaaa</u>","text":"<u>Yaaa</u>","html":"<u>Yaaa</u>"}],"langContent":"CN"},{"id":847255858,"gmtCreate":1636527824235,"gmtModify":1636527824641,"author":{"id":"3570795138700824","authorId":"3570795138700824","name":"assassinyj","avatar":"https://static.tigerbbs.com/c5c10786bc09238ddcb1c4b89e9cfa6e","vip":1,"crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3570795138700824","idStr":"3570795138700824"},"htmlText":"😄","listText":"😄","text":"😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847255858","repostId":2182408236,"repostType":4,"repost":{"id":"2182408236","pubTimestamp":1636527423,"share":"https://www.laohu8.com/m/news/2182408236?lang=&edition=full","pubTime":"2021-11-10 14:57","market":"us","language":"en","title":"Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2182408236","media":"Reuters","summary":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use CO","content":"<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.</p>\n<p>Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.</p>\n<p>Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.</p>\n<p>About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer applies for COVID-19 vaccine approval for 5-11 year olds in Japan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 14:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's ...</p>\n\n<a href=\"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/pfizer-applies-covid-19-vaccine-024741356.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2182408236","content_text":"TOKYO, Nov 10 (Reuters) - Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.\nPfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.\nPfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.\nAbout 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6522825,"gmtCreate":1636527829852,"gmtModify":1636527829945,"authorId":3570795138700824,"author":{"id":3570795138700824,"idStr":"3570795138700824","authorId":3570795138700824,"name":"assassinyj","avatar":"https://static.tigerbbs.com/c5c10786bc09238ddcb1c4b89e9cfa6e","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":847255858,"type":1,"supId":0,"prevId":0,"content":"ha ha","text":"ha ha","html":"ha ha"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":19,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}